Bank of New York Mellon Corp - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 35 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$5,140
+2.8%
14,6850.0%0.00%
Q3 2022$5,000
-28.6%
14,6850.0%0.00%
Q2 2022$7,0000.0%14,6850.0%0.00%
Q1 2022$7,000
-12.5%
14,6850.0%0.00%
Q4 2021$8,000
-46.7%
14,6850.0%0.00%
Q3 2021$15,000
-16.7%
14,6850.0%0.00%
Q2 2021$18,000
-5.3%
14,6850.0%0.00%
Q1 2021$19,000
-69.4%
14,685
-12.6%
0.00%
Q4 2020$62,000
+72.2%
16,7970.0%0.00%
Q3 2020$36,000
+20.0%
16,7970.0%0.00%
Q2 2020$30,000
+36.4%
16,797
-0.0%
0.00%
Q1 2020$22,000
-29.0%
16,798
+0.0%
0.00%
Q4 2019$31,000
-82.1%
16,797
-72.0%
0.00%
Q3 2019$173,000
+45.4%
60,010
+35.1%
0.00%
Q2 2019$119,000
-17.9%
44,409
-22.4%
0.00%
Q1 2019$145,000
-9.4%
57,204
-0.9%
0.00%
Q4 2018$160,000
-69.3%
57,704
-1.5%
0.00%
Q3 2018$521,00058,5570.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 56,250$206,0000.12%
Baker Brothers Advisors 4,608,786$16,914,0000.06%
Artal Group S.A. 500,000$1,835,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 90,000$331,0000.04%
Spotlight Asset Group, Inc. 21,500$79,0000.03%
DCF Advisers, LLC 18,755$69,0000.03%
683 Capital Management, LLC 88,470$325,0000.02%
Palo Alto Investors LP 77,044$283,0000.02%
Alpine Global Management, LLC 13,966$51,0000.01%
TCI Wealth Advisors, Inc. 4,000$15,0000.01%
View complete list of IDERA PHARMACEUTICALS INC shareholders